Home › Non-Small Cell Lung Cancer › Arkansas › Springdale

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Springdale, AR

Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Springdale. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Nagre-recruitPhase 2/3

Highlands Oncology Group - Springdale /ID# 277132, Springdale

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07155187

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 3

Highlands Oncology Group, PA, Springdale
Highlands Oncology Group, Springdale
Highlands Oncology Group, PA, Rogers · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07144280

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Nagre-recruitPhase 3

Highlands Oncology Group-Research Department ( Site 0062), Springdale

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06312137

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Nagre-recruitPhase 3

Highlands Oncology Group, Springdale
Highlands Oncology Group, Rogers · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07222566

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Nagre-recruitPhase 1/2

Highlands Oncology Group, PA, Springdale
Highlands Oncology Group, PA, Rogers · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07227298

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Nagre-recruitPhase 3

Highlands Oncology Group, Springdale

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06890598

Pan-tumor MRD Study

Nagre-recruitObservasyonal na pag-aaral

Highlands Oncology Group (HOG), Springdale

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06605404

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Nagre-recruitPhase 3

Research Site, Springdale

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06357533

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Nagre-recruitPhase 3

Local Institution - 0686, Springdale

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06875310

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 3

Research Site, Springdale

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06692738

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Nagre-recruitPhase 2/3

Highlands Oncology Group - Springdale, Springdale

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT04613596

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Nagre-recruitPhase 3

Highlands Oncology Group, Springdale

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In

Nagre-recruitPhase 3

Highlands Oncology Group, Springdale

Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT06745908

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Nagre-recruitPhase 1

Highlands Oncology Group, Springdale
Highlands Oncology Group, Rogers · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT04389632

BostonGene and Exigent Genomic INsight Study

Nagre-recruitObservasyonal na pag-aaral

Highlands Oncology Group, Rogers · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 17, 2025 · NCT06272864

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Springdale

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.